The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Dumas, Aline ^a   Amiable, Nathalie ^a   de Rivero Vaccari, Juan Pablo ^b   Chae, Jae Jin ^c   Keane, Robert W ^d   Lacroix, Steve ^a,e   Vallières, Luc ^a,e  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF MIAMI   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; PERTUSSIS TOXIN;

ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; METABOLISM; MOUSE; MULTIPLE SCLEROSIS; NEUTROPHIL; T LYMPHOCYTE;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMASOMES; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MULTIPLE SCLEROSIS; MYELOID CELLS; NEUTROPHILS; PERTUSSIS TOXIN; T-LYMPHOCYTES;

EID: 84901651706     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004150     Document Type: Article

References (97)

1. Ascherio A, Munger KL, Lunemann JD, (2012) The initiation and prevention of multiple sclerosis. Nat Rev Neurol 8: 602-612.
2. Koch MW, Metz LM, Agrawal SM, Yong VW, (2013) Environmental factors and their regulation of immunity in multiple sclerosis. J Neurol Sciol 324: 10-612.
3. Marrie RA, Wolfson C, Sturkenboom MC, Gout O, Heinzlef O, et al. (2000) Multiple sclerosis and antecedent infections: a case-control study.sclerosis. NeurologySciol 54: 2307-2310.
4. Hernan MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A, (2001) Multiple sclerosis and age at infection with common viruses. study.sclerosis. Epidemiologyol 12: 301-610.
5. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D, (2004) Multiple sclerosis after infectious mononucleosis: record linkage study.osis. J Epidemiol Community Health 58: 1032-1050.
6. Thacker EL, Mirzaei F, Ascherio A, (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis.is. Ann Neurol 59: 499-503.
7. Nielsen TR, Rostgaard K, Nielsen NM, Koch-Henriksen N, Haahr S, et al. (2007) Multiple sclerosis after infectious mononucleosis.erosis: a meta-analysis.is. Arch Neurol 64: 72-5503.
8. Ascherio A, Munger KL, (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neuroll 61: 288-993.
9. Zaadstra BM, Chorus AM, van Buuren S, Kalsbeek H, van Noort JM, (2008) Selective association of multiple sclerosis with infectious mononucleosis.ection. Mult Sclerl 14: 307-133.
10. Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, et al. (2009) Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology 32: 257-623.
11. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, et al. (2010) An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 5: e12496.
12. Sibley WA, Bamford CR, Clark K, (1985) Clinical viral infections and multiple sclerosiserosis following infectious mononucleosis. Lancet 1: 1313-1353.
13. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A, (1993) Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 240: 417-223.
14. Panitch HS, (1994) Influence of infection on exacerbations of multiple sclerosisective seroepidemiological study. Ann Neurol 36 (Suppl): S25-823.
15. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD, (1998) Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 64: 736-413.
16. Buljevac D, Flach HZ, Hop WC, Hijdra D, Laman JD, et al. (2002) Prospective study on the relationship between infections and multiple sclerosis exacerbations.er respiratory tract infections in multiple sclerosis. Brain 125: 952-603.
17. Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, et al. (2008) Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.is exacerbations.er respiratory tract infections in multiple sclerosis. Neuroepidemiology 31: 271-903.
18. Munz C, Lunemann JD, Getts MT, Miller SD, (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunolgy 9: 246-583.
19. Kakalacheva K, Munz C, Lunemann JD, (2011) Viral triggers of multiple sclerosis.of or triggered by autoimmunity? Biochim Biophys Acta 1812: 132-403.
20. Goverman J, Woods A, Larson L, Weiner LP, Hood L, et al. (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-603.
21. Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, et al. (2008) NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora.ous autoimmunity. Am J Pathol 173: 1714-1723.
22. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK, (2011) Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.immunity. Proc Natl Acad Sci U S A 108 (Suppl 1): 4615-4622.
23. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, et al. (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.lomyelitis.immunity. Nature 479: 538-412.
24. Stromnes IM, Goverman JM, (2006) Active induction of experimental allergic encephalomyelitis.gger autoimmune demyelination.lomyelitis.immunity. Nat Protoc 1: 1810-1892.
25. Stromnes IM, Goverman JM, (2006) Passive induction of experimental allergic encephalomyelitis.ger autoimmune demyelination.lomyelitis.immunity. Nat Protoc 1: 1952-1960.
26. Carbonetti NH, (2010) Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol 5: 455-690.
27. Plaut RD, Carbonetti NHM, (2008) Retrograde transport of pertussis toxin in the mammalian cell.tors of Bordetella pertussis and cell biology tools. Cell Microbiolol 10: 1130-1190.
28. Bokoch GM, Katada T, Northup JK, Hewlett EL, Gilman AG, (1983) Identification of the predominant substrate for ADP-ribosylation by islet activating protein.d cell biology tools. J Biol Chemiolol 258: 2072-2050.
29. Codina J, Hildebrandt J, Iyengar R, Birnbaumer L, Sekura RD, et al. (1983) Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A 80: 4276-4280.
30. Mangmool S, Kurose H, (2011) G(i/o) protein-dependent and-independent actions of Pertussis Toxin (PTX).is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Toxins (Basel) Sci U S A 3: 884-990.
31. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, et al. (2004) TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune diseaser regulated by guanine nucleotide and magnesium. J Immunol 173: 7070-7070.
32. Richard JF, Roy M, Audoy-Remus J, Tremblay P, Vallieres L, (2011) Crawling phagocytes recruited in the brain vasculature after pertussis toxin exposure through IL6, ICAM1, and ITGαM. guanine nucleotide and magnesium. Brain Pathol 21: 661-671.
33. Roy M, Richard JF, Dumas A, Vallieres L, P, Vallieres L, (2012) CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis.magnesium. J Neuroinflammation 9: 18.
34. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
35. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-201.
36. Schroder K, Tschopp J, (2010) The inflammasomes. Cell 140: 821-321.
37. Rathinam VA, Vanaja SK, Fitzgerald KA, (2012) Regulation of inflammasome signaling. Nat Immunol 13: 333-221.
38. Latz E, Xiao TS, Stutz A, KA, (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13: 397-411.
39. Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, et al. (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chemunol 276: 39320-39329.
40. Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, et al. (2006) Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization.ed apoptosis. Cell Death Differ 13: 236-499.
41. Yu JW, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, et al. (2007) Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cellth Differ 28: 214-279.
42. Gavrilin MA, Mitra S, Seshadri S, Nateri J, Berhe F, et al. (2009) Pyrin critical to macrophage IL-1beta response to Francisella challenge.lammatory PSTPIP1 mutants. J Immunolh Differ 182: 7982-7999.
43. Gavrilin MA, Abdelaziz DH, Mostafa M, Abdulrahman BA, Grandhi J, et al. (2012) Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia.ry PSTPIP1 mutants. J Immunolh Differ 188: 3469-3477.
44. Yu JW, Farias A, Hwang I, Fernandes-Alnemri T, Alnemri ES, (2013) Ribotoxic stress through p38 mitogen-activated protein kinase activates in vitro the human pyrin inflammasome. J Biol ChemDiffer 288(16): 11378-83.
45. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, et al. (2003) Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol CellhemDiffer 11: 591-604.
46. Chae JJ, Wood G, Masters SL, Richard K, Park G, et al. (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 103: 9982-9974.
47. Papin S, Cuenin S, Agostini L, Martinon F, Werner S, et al. (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differi U S A 14: 1457-1466.
48. Hesker PR, Nguyen M, Kovarova M, Ting JP, Koller BH, et al. (2012) Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1beta levels.ponents and inhibits proIL-1beta processing. PLoS One 7: e511056.
49. Gowing G, Vallieres L, Julien JP, (2006) Mouse model for ablation of proliferating microglia in acute CNS injuries. Glia One 53: 331-756.
50. Matsushima H, Ogawa Y, Miyazaki T, Tanaka H, Nishibu A, et al. (2010) Intravital imaging of IL-1beta production in skin.a in acute CNS injuries. J Invest Dermatol 130: 1571-1580.
51. Pizza M, Covacci A, Bartoloni A, Perugini M, Nencioni L, et al. (1989) Mutants of pertussis toxin suitable for vaccine development. CNS injuries. Science 246: 497-500.
52. Vallieres L, Sawchenko PE, (2003) Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 23: 5197-5207.
53. Audoy-Remus J, Richard JF, Soulet D, Zhou H, Kubes P, et al. (2008) Rod-Shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2. J Neurosci 28: 10187-10199.
54. Carlson T, Kroenke M, Rao P, Lane TE, Segal B, P, et al, (2008) The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. proinflammatory cytokines and angiopoietin-2. J Exp Medi 205: 811-2399.
55. Christy AL, Walker ME, Hessner MJ, Brown MAB, (2013) Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.ase. proinflammatory cytokines and angiopoietin-2. J Autoimmun 42: 50-61399.
56. Steinbach K, Piedavent M, Bauer S, Neumann JT, Friese MA, (2013) Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs. the meninges in EAE.ase. proinflammatory cytokines and angiopoietin-2. J Immunolun 191(9): 4531-9.
57. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, et al. (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.mmatory cytokines and angiopoietin-2. J Exp Medun 197: 1073-1819.
58. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, et al. (2012) Alarmins: awaiting a clinical response. J Clin Invest 122: 2711-2919.
59. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90: 797-8079.
60. French FMF Consortium Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17: 25-31079.
61. Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, et al. (1998) Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 7: 1317-1259.
62. Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, et al. (2003) Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immunet 4: 197-2039.
63. Unal A, Dursun A, Emre U, Tascilar NF, Ankarali HI, et al. (2010) Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: is it a susceptibility gene?ewish multiple sclerosis patients. J Neurol Scit 294: 38-42039.
64. Yahalom G, Kivity S, Lidar M, Vaknin-Dembinsky A, Karussis D, et al. (2011) Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts?ewish multiple sclerosis patients. Eur J Neurolt 18: 1146-1509.
65. Kumpfel T, Gerdes LA, Wacker T, Blaschek A, Havla J, et al. (2012) Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis.MF cohorts?ewish multiple sclerosis patients. Mult Sclerolt 18: 1229-1389.
66. Maatta JA, Sjoholm UR, Nygardas PT, Salmi AA, Hinkkanen AE, (1998) Neutrophils secreting tumor necrosis factor alpha infiltrate the central nervous system of BALB/c mice with experimental autoimmune encephalomyelitis.tients. J Neuroimmunol 90: 162-7589.
67. Reiseter BS, Miller GT, Happ MP, Kasaian MT, (1998) Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid. J Neuroimmunol 91: 156-7089.
68. Tran EH, Prince EN, Owens T, MP, Kasaian MT, (2000) IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunolmunol 164: 2759-2689.
69. Reddy J, Waldner H, Zhang X, Illes Z, Wucherpfennig KW, et al. (2005) Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J Immunolmunol 175: 5591-5589.
70. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM, KW, Sobel RA, et al. (2008) IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Medmunol 205: 1535-1419.
71. Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, et al. (2009) Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.S chemokine profile, and response to cytokine inhibition. J Neurosciunol 29: 14965-14979.
72. Wu F, Cao W, Yang Y, Liu A, (2010) Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 mice.e to cytokine inhibition. Histochem Cell Biol 133: 313-2279.
73. Kang Z, Altuntas CZ, Gulen MF, Liu C, Giltiay N, et al. (2010) Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.o cytokine inhibition. Immunity 32: 414-2579.
74. McColl SR, Staykova MA, Wozniak A, Fordham S, Bruce J, et al. (1998) Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis.itis.o cytokine inhibition. J Immunol 161: 6421-6679.
75. Liu L, Darnall L, Hu T, Choi K, Lane TE, et al. (2010) Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.erimental autoimmune encephalomyelitis.itis.o cytokine inhibition. J Neurosci 30: 9074-9839.
76. Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, et al. (2012) Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.myelitis.itis.o cytokine inhibition. Ann Neurol 71: 323-3339.
77. Naegele M, Tillack K, Reinhardt S, Schippling S, Martin R, et al. (2012) Neutrophils in multiple sclerosis are characterized by a primed phenotype. G-induced damage in mouse brain.myelitis.itis.o cytokine inhibition. J Neuroimmunol 242: 60-71339.
78. Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, et al. (2004) Increased CXCL8 (IL-8) expression in Multiple Sclerosis. J Neuroimmunol 155: 161-7139.
79. Bangs SC, McMichael AJ, Xu XN, (2006) Bystander T cell activation-implications for HIV infection and other diseases. Trends Immunol 27: 518-2439.
80. Gijbels K, Brocke S, Abrams JS, Steinman L, (1995) Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol MedImmunol 1: 795-8059.
81. Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y, (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.f IL-6 bioactivity in central nervous system and circulation. J Immunolmunol 161: 6480-6659.
82. Okuda Y, Sakoda S, Bernard CC, Fujimura H, Saeki Y, et al. (1998) IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.ive T cells.f IL-6 bioactivity in central nervous system and circulation. Int Immunolnol 10: 703-8659.
83. Eugster HP, Frei K, Kopf M, Lassmann H, Fontana AY, et al. (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunoll 28: 2178-2879.
84. Okuda Y, Sakoda S, Fujimura H, Saeki Y, Kishimoto T, et al. (1999) IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J Neuroimmunol 101: 188-9679.
85. Arima Y, Harada M, Kamimura D, Park JH, Kawano F, et al. (2012) Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier.xperimental autoimmune encephalomyelitis. Cell 148: 447-5779.
86. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B, (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.oimmune encephalomyelitis. Immunity 24: 179-8979.
87. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.ucing T cells.oimmune encephalomyelitis. Naturety 441: 235-8979.
88. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, et al. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage.r TH17 and regulatory T cells.ucing T cells.oimmune encephalomyelitis. Naturety 441: 231-4979.
89. Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, et al. (2008) IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.omyelitis. Proc Natl Acad Sci U S A 105: 9041-9679.
90. Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, et al. (2008) Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. autoimmune encephalomyelitis.omyelitis. Immunity 29: 628-3679.
91. Zhao L, Tang Y, You Z, Wang Q, Liang S, et al. (2011) Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.halomyelitis.omyelitis. PLoS One 6: e1890979.
92. Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, et al. (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis.interleukin-6 expression.halomyelitis.omyelitis. J Biol Chem 276: 39320-39399.
93. Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, et al. (2003) Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.itis.omyelitis. Proc Natl Acad Sci U S A 100: 13501-13569.
94. Papin S, Cuenin S, Agostini L, Martinon F, Werner S, et al. (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differi U S A 14: 1457-1669.
95. Luu-The V, Paquet N, Calvo E, Cumps J, (2005) Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction.its proIL-1beta processing. Biotechniquesfferi U S A 38: 287-9369.
96. Villeneuve J, Tremblay P, Vallieres L, (2005) Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation.ble correction.its proIL-1beta processing. Cancer Res 65: 3928-3369.
97. Bouchard C, Page J, Bedard A, Tremblay P, Vallieres L, (2007) G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditionsation.ble correction.its proIL-1beta processing. Glia 55: 790-8009.